https://orcid.org/0000-0001-7156-4637
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xin-Yue Yang, Lina Geng, Ronghui Li, Ji-Xian Song, Cui-Ling Jia, Ji-Ren An, Meng-Fan Sun, Shan Xu, Ya-Jing Guo, Yashuo Zhao & En-Sheng Ji. (2023) Huperzine A-Liposomes Efficiently Improve Neural Injury in the Hippocampus of Mice with Chronic Intermittent Hypoxia. International Journal of Nanomedicine 18, pages 843-859.
Read now
Read now
Mina Y. George, Marwa O. El-Derany, Yasmine Ahmed, Malvina Zaher, Caroline Ibrahim, Habiba Waleed, Hajar Khaled, Gehad Khaled, Ahmed Saleh, Huda Alshafei, Rahma Alshafei, Nirmeen Ahmed, Sara Ezz, Nouran Ashraf & Shaimaa S. Ibrahim. (2023) Design and evaluation of chrysin-loaded nanoemulsion against lithium/pilocarpine-induced status epilepticus in rats; emphasis on formulation, neuronal excitotoxicity, oxidative stress, microglia polarization, and AMPK/SIRT-1/PGC-1α pathway. Expert Opinion on Drug Delivery 20:1, pages 159-174.
Read now
Read now
Shourya Tripathi, Ujala Gupta, Rewati Raman Ujjwal & Awesh K. Yadav. (2021) Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route. Journal of Microencapsulation 38:7-8, pages 572-593.
Read now
Read now
Articles from other publishers (26)
Linghui Li, Liwei Tan, Qian Zhang, Yushan Cheng, Yayuan Liu, Rui Li & Shuguang Hou. (2023) Nose-to-brain delivery of self-assembled curcumin-lactoferrin nanoparticles: Characterization, neuroprotective effect and in vivo pharmacokinetic study. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Shashi Kiran Misra & Kamla Pathak. (2023) Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence. Colloids and Interfaces 7:1, pages 23.
Crossref
Crossref
Fabiola Guzmán-Mejía, Marycarmen Godínez-Victoria, Daniel Efrain Molotla-Torres & Maria Elisa Drago-Serrano. (2023) Lactoferrin as a Component of Pharmaceutical Preparations: An Experimental Focus. Pharmaceuticals 16:2, pages 214.
Crossref
Crossref
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral & Paulo C. Costa. (2023) Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases. Colloids and Surfaces B: Biointerfaces 221, pages 112999.
Crossref
Crossref
Seung-Hyun Jeong, Ji-Hun Jang & Yong-Bok Lee. (2022) Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. Journal of Pharmaceutical Investigation 53:1, pages 119-152.
Crossref
Crossref
Thu Kim Dang, Seong‐Min Hong, Vui Thi Dao, Duong Thuy Nguyen, Khanh Van Nguyen, Hai Thanh Nguyen, Sana Ullah, Hiep Tuan Tran & Sun Yeou Kim. (2022)
Neuroprotective effects of total alkaloids fraction of
Huperzia serrata
on
scopolamine‐induced
neurodegenerative animals
. Phytotherapy Research 37:1, pages 140-150.
Crossref
Crossref
Li Li, Rendong He, Haili Yan, Zhengwei Leng, Shuang Zhu & Zhanjun Gu. (2022) Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis. Nano Today 47, pages 101654.
Crossref
Crossref
Yueyao Jiang, Yichuan Jiang, Zhiying Ding & Qian Yu. (2022) Investigation of the “Nose-to-Brain” Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability. International Journal of Nanomedicine Volume 17, pages 3443-3456.
Crossref
Crossref
Philippe Delbreil, Jean-Michel Rabanel, Xavier Banquy & Davide Brambilla. (2022) Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings. Advanced Drug Delivery Reviews 187, pages 114397.
Crossref
Crossref
Mohamad Taleuzzaman, Sanjay Chauhan, Devendra Singh Tomar, Pankaj Kumar Singh, Isha Talwar & Md Noushad Javed. 2022. Nanotechnology in Functional Foods. Nanotechnology in Functional Foods
161
191
.
Nikita Katila, Ramesh Duwa, Sunil Bhurtel, Shristi Khanal, Srijan Maharjan, Jee-Heon Jeong, Sooyeun Lee, Dong-Young Choi & Simmyung Yook. (2022) Enhancement of blood–brain barrier penetration and the neuroprotective effect of resveratrol. Journal of Controlled Release 346, pages 1-19.
Crossref
Crossref
Prashant Poudel & Soyeun Park. (2022) Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems. Pharmaceutics 14:4, pages 835.
Crossref
Crossref
Nikita Subhash Hinge, Himanshu Kathuria & Murali Monohar Pandey. (2022) Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's. Applied Materials Today 26, pages 101303.
Crossref
Crossref
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Nguyen-Minh-An Tran & Giau Van Vo. (2021) Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders. Neurochemical Research 47:3, pages 552-573.
Crossref
Crossref
Leonard I. Atanase. 2022. Systems of Nanovesicular Drug Delivery. Systems of Nanovesicular Drug Delivery
17
37
.
Francisca Espinoza, Walther Ide, Natalia Saldivia & Diego Zelada. 2022. Polymeric Biomaterials for Healthcare Applications. Polymeric Biomaterials for Healthcare Applications
369
402
.
Luis F. González, Lorenzo E. Bevilacqua & Rodrigo Naves. (2021) Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases. Pharmaceutics 13:12, pages 2055.
Crossref
Crossref
Lin Wang, Yinghong Li, Qianqian Jiang, Manyin Chen & Zhengzhi Wu. (2021) Anti-Alzheimer’s disease performance of triptolide nanoliposomes modified with lactoferrin. Materials Express 11:7, pages 1116-1121.
Crossref
Crossref
Mukta Agrawal, Eluri Prathyusha, Hafiz Ahmed, Sunil Kumar Dubey, Prashant Kesharwani, Gautam Singhvi, V.G.M. Naidu & Amit Alexander. (2021) Biomaterials in treatment of Alzheimer's disease. Neurochemistry International 145, pages 105008.
Crossref
Crossref
Cláudia Pina Costa, João Nuno Moreira, José Manuel Sousa Lobo & Ana Catarina Silva. (2021) Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharmaceutica Sinica B 11:4, pages 925-940.
Crossref
Crossref
Mona M. Agwa & Sally Sabra. (2021) Lactoferrin coated or conjugated nanomaterials as an active targeting approach in nanomedicine. International Journal of Biological Macromolecules 167, pages 1527-1543.
Crossref
Crossref
Rahul Shukla, Ashish Kumar & S.J.S. Flora. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
73
91
.
Shiv Bahadur, Dinesh M. Pardhi, Jarkko Rautio, Jessica M. Rosenholm & Kamla Pathak. (2020) Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders. Pharmaceutics 12:12, pages 1230.
Crossref
Crossref
Natália N. Ferreira, Sara Granja, Fernanda I. Boni, Fabíola G. Prezotti, Leonardo M. B. Ferreira, Beatriz S. F. Cury, Rui M. Reis, Fátima Baltazar & Maria Palmira D. Gremião. (2020) Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route. Drug Delivery and Translational Research 10:6, pages 1729-1747.
Crossref
Crossref
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Crossref
Amira G. Zaki, El-Sayed R. El-Sayed, M. Abd Elkodous & Gharieb S. El-Sayyad. (2020) Microbial acetylcholinesterase inhibitors for Alzheimer’s therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery. Applied Microbiology and Biotechnology 104:11, pages 4717-4735.
Crossref
Crossref